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The protein Rv0020c from Mycobacterium
tuberculosis, also called FhaA, is one of the major
substrates of the essential Ser/Thr protein kinase
(STPK) PknB. The protein is composed of three
domains and is phosphorylated on a unique site in
its N terminus. We solved the solution structure of
both N- and C-terminal domains and demonstrated
that the approximately 300 amino acids of the inter-
mediate domain are not folded. We present evidence
that the FHA, a phosphospecific binding domain, of
Rv0020c does not interact with the phosphorylated
catalytic domains of PknB, but with the phosphory-
lated juxtamembrane domain that links the catalytic
domain to the mycobacterial membrane. We also
demonstrated that the degree and the pattern of
phosphorylation of this juxtamembrane domain
modulates the affinity of the substrate (Rv0020c)
toward its kinase (PknB).
INTRODUCTION
The eukaryotic-like Ser/Thr protein kinases (STPKs) control
numerous pathways in Mycobacterium tuberculosis, including
cell growth initiation, cell division, metabolic flux, or transcrip-
tion. STPKs substrates linked to novel phosphoregulation
pathways are continuously discovered (Alber, 2009; Molle and
Kremer, 2010). Among the numerous substrates identified for
the 11 M. tuberculosis STPKs, a family can be defined by the
presence of a approximately 80 amino acids ForkHead Associ-
ated (FHA) domain. The FHA domain is a phosphopeptide-
specific binding domain found in bacteria, yeasts, plants, or
mammalians, able to specifically bind to sequences containing
phosphothreonine (Mahajan et al., 2008). In M. tuberculosis,
five FHA-containing proteins are present with no apparent
functional link, all of them being STPKs substrates. The first
mycobacterial FHA-containing protein identified was the pro-
tein EmbR (Alderwick et al., 2006), a transcriptional regulator
involved in regulating arabinogalactan biosynthesis, whichStructure 19, 1525–1DNA binding activity is modulated by PknH phosphorylation
(Molle et al., 2003). Rv1747 is an ABC transporter, which is
necessary for growth of M. tuberculosis in vivo and contains
two FHA domains being specifically recognized by the myco-
bacterial kinase PknF (Curry et al., 2005; Molle et al., 2004).
Experiments to determine how PknF regulates the function of
Rv1747 demonstrated that phosphorylation occurs on two
specific threonine residues, and positively modulates Rv1747
function in vivo via its FHA-1 domain (V. Molle, unpublished
data). GarA (Rv1827) is a TCA regulator. It has been shown
that the unfolded N-terminal extension of the FHA domain is
phosphorylated on two different sites by either PknG or PknB
and that phosphorylation promotes the inhibition of the protein
and releases the repression of the glutamate dehydrogenase,
the a-ketoglutarate decarboxylase and a subunit of the gluta-
mine synthetase, three major TCA enzymes (O’Hare et al.,
2008). The two last members of this FHA-family are Rv0020c
and Rv0019c, also called FhaA and FhaB, respectively. Their
functions remain unknown, but their corresponding genes are
located upstream of the kinases pknB (rv0014c) and pknA
(rv0015c), the penicillin binding protein pbpA (rv0016c), the cell
division protein rodA (rv0017c), and the Ser/Thr phosphatase
ppp (rv0018c) genes. As a consequence, it has been postulated
that the function of Rv0020c and Rv0019c may be linked to the
cell wall biosynthesis and/or its regulation (Fernandez et al.,
2006). This hypothesis has been strengthened in a recent study
proposing that Rv0019c could regulate PapA5, a protein
involved in phthiocerol dimycocerosate biosynthesis (Gupta
et al., 2009). However, the mode of action at a molecular level
remains to be elucidated. The domain architecture of this protein
is supposed to be similar to GarA (V. Molle, unpublished data).
Rv0020c is a larger protein (527 aa), with a C-terminal FHA
domain linked to a approximately 130 amino acids N-terminal
domain of unknown function by a 300 residues Pro/Gly rich inter-
mediate domain. No functional data are available on Rv0020c,
and no precise function has been proposed.
In this study, we first solved the solution structure of both
Rv0020c N-terminal and C-terminal domains by NMR. We
showed that the intermediate domain is unfolded and that
the N- and C-terminal domains behave independently. We
determined the phosphorylation site of Rv0020c and demon-
strated that the phosphorylation does not induce any structural534, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1525
Figure 1. Superimposition of the [1H,15N] HSQC
SpectraofFull-Length,N-Terminal, andC-Terminal
Domains of Rv0020c
Superimposition of the [1H,15N] HSQC spectra obtained at
700 MHz (pH 6.8 and 20C), of Rv0020c full-length (black),
Rv0020c_FHA (blue), and Rv0020c_Nter (red). The aver-
aged chemical shift differences (Dd) as a function of the
proteinsequencearegiven inFigureS1.SeealsoFigureS2.
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PknB/Rv0020c Interaction Studychanges as observed for GarA (Barthe et al., 2009; Nott et al.,
2009), linked to an autoinhibition mechanism. Furthermore, we
investigated the interaction between Rv0020c and the kinase
PknB. We showed that the FHA domain of Rv0020c binds with
high affinity to the phosphorylated PknB, and that this interaction
involves the STPK juxtamembrane domain and not the catalytic
domain itself. Finally, we presented evidences of affinity modu-
lation dependent of the phosphorylation pattern of the PknB
juxtamembrane domain, suggesting that a phosphorylation site
was predominant. These complex interactions between the
FHA substrate and its kinase illustrate the elaborate phosphore-
gulation network in M. tuberculosis and bring new features into
the function of FHA containing STPKs substrates.
RESULTS AND DISCUSSION
Domain Delimitation
Bioinformatics studies using different web-based servers al-
lowed us to identify the approximately 95 residues FHA domain
(residues 430–527) within the 527 amino acid sequence of
Rv0020c. From multiple-sequence analysis and hydrophobic
cluster analysis (Callebaut et al., 1997), an N-terminal domain
(residues 1–132) emerges with no apparent similarities with
known proteins. In between these two domains (residues 133–
429), the protein possesses a 300 amino acids PG-rich ‘‘domain’’
(proline: 17.2%; glycine: 23.2%), with a very low content in
hydrophobic residues (Ile+Leu+Met+Phe+Trp+Val: 3%) except
for the tyrosine (13.6%). The low content in hydrophobic resi-
dues of this intermediate domain allowed us to define precisely
its delimitations. Direct Rv0020c homologs, with homologous1526 Structure 19, 1525–1534, October 12, 2011 ª2011 Elsevier Ltd All rights reservedsequences for both N-ter and Cter domains,
exist for closely related organisms. Noteworthy
some of these proteins lack the intermediate
PG-rich domain and only possess the
N-terminal and the FHA domain, while some
close homolog have a slightly shorter interme-
diate PG-rich domain (20 residues shorter in
M. avium and 50 residues for M. leprae). To
initiate the structural and interaction studies
we cloned the N-terminal (Rv0020c_Nter) and
the FHA (Rv0020c_FHA) domain separately in
addition to the full-length protein.
The Structure of the N- and C-terminal
Domains Are Similar in the Isolated
or in the Full-Length Proteins
Confirming the bioinformatic analysis, the
spectra of Rv0020c-Nter and Rv0020c_FHA
form complementary subsets of the spectrumfrom full-length Rv0020c (Figure 1): cross-peaks in the [1H,15N]
HSQC spectra of each isolated domain protein overlap with
a cross-peak in the [1H,15N] HSQC spectrum of the full-length
protein, showing only weak chemical shift variations that
concern essentially the C-terminal FHA domain (see Figure S1
available online). This suggests that residues from the N- and
C-terminal domain are in a similar environment either in the
full-length construct or in an isolated domain, supporting that
the Nter and FHA domains constitute independently folded
modules, without any interaction between the two domains.
Moreover, the resonance line widths measured in the three
spectra for the N- and C-terminal domains are very similar,
further indicating that these domains are significantly dynami-
cally decoupled. The others residues, corresponding to the
133–429 PG-rich peptidic segment, gave rise to the intense
cross-peaks centered at 8.5 ppm in the proton dimension of
the [1H,15N] HSQC spectrum of the full-length protein, thus
strongly suggesting that this segment adopts a random-coil
conformation. From these observations, we decided to solve
the solution structure of the N- and C-terminal domain of
Rv0020c independently.
NMR Structures of the N-Terminal and the C-Terminal
Domains
The assigned [1H,15N] HSQC spectrum of Rv0020c_Nter and
Rv0020c_FHA are shown in Figure S2. By combining the infor-
mation from the double- and triple-resonance heteronuclear
experiments, we were able to assign 94.5% and 99% of the
amide group resonances for the nonproline residues (four
and two prolines), 92.9% and 100% of the other backbone
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Figure 2. Cartoon Representation of the Rv0020c_FHA Structure
(A) The N-terminal part of the protein from Gly430 to Gly433 is disordered and
represented in gray.
(B) Representation of the final ensemble of 30 NMR structures of Rv0020c_FHA.
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Figure 3. Cartoon Representation of the Rv0020c_Nter Structure
(A) The N-terminal part of the protein from Met1 to Val32 is disordered and
represented in gray.
(B) Representation of the final ensemble of 30 NMR structures of Rv0020c_Nter.
See also Figure S3.
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PknB/Rv0020c Interaction Studyresonances (Ca, C’ and Ha), 85.7% and 100% of the Cb
resonances, and 84.1% and 94.4% of the side-chain protons
for Rv0020c_Nter and Rv0020c_FHA, respectively. The
chemical shift table was deposited in the BMRB databank
(accession numbers 17585 and 17586 for Rv0020c_Nter and
Rv0020c_FHA, respectively).
CYANA calculations performed for the C-terminal domain of
Rv0020c revealed a well-defined FHA domain. The global fold
of the FHA domain, a b sandwich composed of 11 strands, is
well conserved (Figure 2) and similar to the recently X-ray
structure (PDB 3PO8) determined for the same domain (root-
mean-square deviation [rmsd] of 1.5 A˚) (Pennell et al., 2010).
In the case of the N-terminal domain, the calculation yields
a less canonical structure: the domain folds into a globular
structure, encompassing a triple stranded b sheet flanked on
one side by two amphipatic a helices (a1, a3), with a topology
of a1b3a3b1ß2 (Figure 3). Helix 1 (Pro33-Asp46) and helix 3
(Glu79-Glu95) adopt a parallel disposition, with an angle of
around 45 relative to each other. Strand b2 (Val105-Gln110) is
oriented parallel to b1 (Glu61-Leu66), while b3 (Arg120-Gly123)
is antiparallel to b1. This ab sandwich is stabilized by numerous
hydrophobic contacts between helix 1 and 3 and the hydro-
phobic face of the triple stranded b sheet. A third short helix a2
(Val68-Leu74) caps one extremity of this ab sandwich. Consis-
tent with the absence of long-range NOEs, the 32 first residues
adopt a random-coil conformation, with the exception of resi-
dues Ala22 to Phe27 that form a short dynamic helix, essentially
defined by TALOS restraints. The coordinates have been depos-
ited in the PDB: 2LC0 for the N-terminal domain and 2LC1 for the
FHA C-terminal domain of Rv0020c.
The DALI (Holm and Rosenstro¨m, 2010) and SSM (Krissinel
and Henrick, 2004) servers were used to find possible structural
homologs for Rv0020c_Nter. The best and only reliable result
corresponds to the HypA protein from Helicobacter pylori,
a putative metallochaperone for the [NiFe] hydrogenase matu-
ration (PDB 2KDX, Figure S3). This protein is a weak Ni2+ and
strong Zn2+ binding protein (Xia et al., 2009). The structuralStructure 19, 1525–1conservation is only engulfing the core of the secondary struc-
ture composed by the a helices a1, a3 and the b strands, b1,
b2, and b3 (rmsd of 3.2 A˚ for 80 aa). The a helix a2 located
between the b1 and a3 is absent in HypA. Also, the a1/b1 (resi-
dues 48–58) and a3/b3 (residues 97–104) loops are longer in
Rv0020c_Nter. The accessory Zn2+ binding domain of HypA is
missing in the Rv0020c_Nter domain, replaced by a short loop
between the b strand b2 and b3 (Rv0020c_Nter numbering).
The low affinity binding site for Ni2+ was characterized and is
composed of the residues His2, Glu3, and Asp40 in HypA. While
the equivalent Glu is present in Rv0020c_Nter, the two other resi-
dues at equivalent positions are neither conserved nor homolo-
gous. Thus, after examination of these two related domains, no
related functional property could be deduced from the compar-
ison between the proteins Rv00020c and HypA. Consequently,
only based on the structure knowledge, no conclusion could
be drawn on the putative function of the Rv0020c N-terminal
domain.
Rv0020c Is Phosphorylated at a Unique Threonine
Residue
Recombinant Rv0020c protein was incubated with cold ATP in
the presence of PknB, and subjected to mass spectrometry
analysis after tryptic digestion. ProteinPilot database searching
software (version 2.0, Applied Biosystems), using the Paragon
method with phosphorylation emphasis, was used to detect
and identify the phosphorylated peptides. The sequence
coverage of the protein was 97% and phosphorylation occurred
only on peptide [108–120]. The MS/MS spectrum of the corre-
sponding triple charged ion at m/z 544.2 unambiguously
confirmed the presence of the phosphate group on the threonine
residue Thr116 (Figure S4). Definitive identification and localiza-
tion of Thr116 as being the unique phosphorylation site in
Rv0020c was achieved by site-directed mutagenesis to intro-
duce a mutation that prevents specific phosphorylation
(Thr116 to Ala116 replacement). This mutant was expressed,
purified, and used in an in vitro kinase assay. The recombinant534, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1527
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Figure 4. In Vitro Phosphorylation of the Rv0020c Derivatives by
PknB_331
Purified Rv0020c_WT and Rv0020c_T116A were incubated with PknB_331
and [g-33]ATP. Samples were separated by SDS-PAGE, stained with
Coomassie blue (upper panel) and visualized by autoradiography (lower panel)
after overnight exposure to a film, as indicated. Upper bands reflect the
autophosphorylation activity of Rv0020c and the lower bands correspond to
the autophosphorylation signal of PknB_331. See also Figures S4 and S5.
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PknB/Rv0020c Interaction StudyRv00020c_T116A was incubated along with [g-33P]ATP and
PknB. The mixture was separated by SDS-PAGE and analyzed
by autoradiography. As shown in Figure 4 (upper panel), equal
amounts of Rv0020c_WT or mutant Rv00020c_T116A were
used. Phosphorylation of Rv0020c_T116A was completely
abrogated, compared with phosphorylation of Rv0020c_WT,
as evidenced by the absence of a specific radioactive band (Fig-
ure 4, lower panel). These results unambiguously demonstrate
that Rv00020c_T116A has lost its ability to be phosphorylated
by PknB. Moreover, an additional round of mass spectrometry
analysis was performed on Rv00020c_T116A pretreated with
cold ATP and PknB, which failed to identify any additional
phosphate group that could eventually have arisen as a com-
pensatory mechanism due to the loss of the Thr116 phosphory-
lation (data not shown). Noteworthy, the phosphorylation site is
located in the short loop between the b strand b2 and b3, where
the accessory Zn2+ binding domain is found in HypA (see above).
No Interaction Detected between the Phosphorylated
N-Terminal Domain and the FHA C-Terminal Domain
The modular organization of Rv0020c with a phosphorylated
N-terminal domain and a C-terminal FHA domain linked by
a long unfolded segment prompted us to test whether the two
domains could bind to each other in a phosphorylation-depen-
dent manner. Such interaction has been shown for GarA and1528 Structure 19, 1525–1534, October 12, 2011 ª2011 Elsevier Ltdits close homolog OdhI, two others PknB substrates bearing
a FHA domain, thus revealing a new autoinhibition mechanism
(Barthe et al., 2009; Nott et al., 2009). A [1H,15N] HSQC spectrum
of Rv0020c_Nter was recorded at pH 6.8 at 20C. The protein
was then incubated with PknB, ATP and Mg2+ and repurified.
A new [1H,15N] HSQC spectrum of Rv0020c_Nter now phos-
phorylated (called Rv0020c_Nter_P) was recorded and com-
pared to the one recorded before phosphorylation. In agreement
with mass spectrometry, the phosphorylation yields chemical
shift variations limited to Thr116 (Dv z0.1 ppm for 1H, and
0.2 ppm for 15N), suggesting that the structure of the N-terminal
domain remains virtually unchanged upon phosphorylation (Fig-
ure S5). Note that, at this pH, chemical shift variations of larger
amplitude are expected for the phosphorylated threonine as
well as for residues sequentially or spatially close to this residue,
due to electrostatic perturbations arising from the negatively
charged phosphate group. A closer look to Rv0020c_Nter
NMR structure shows that Thr116 side chain is wedged between
two imidazole rings of the spatially neighbor residues His69 and
His115. This side-chain stacking probably compensates partially
for the charge of the phosphate group, thus limiting its electro-
static effects.
The 15N-labeled sample of Rv0020c_Nter_P was then titrated
with increasing amounts of unlabeled Rv0020c_FHA. The final
Rv0020c_Nter_P:Rv0020c_FHA ratio tested was 1:5 for an initial
concentration of Rv0020c_Nter_P of 50 mM. Since no chemical
shift perturbation upon addition of Rv0020c_FHA (data not
shown) was observed, we can conclude that no interaction
occurs between the two domains upon phosphorylation of
Rv0020c_Nter by PknB, and that the autoinhibition mechanism
observed for GarA and OdhI is apparently not similar in the
case of Rv0020c.
Interaction with PknB
While the role of the FHA domain is now partly understood for
the GarA protein, the function of this domain in the others FHA
containing proteins in M. tuberculosis remains elusive. As a
phosphospecific binding domain, one hypothesis would be
that the FHA domain could promote the substrate recruitment
by the STPKs, and especially by PknB, since PknB phosphory-
lates all the FHA containing proteins (unpublished results). Auto-
phosphorylation patterns are present on the PknB protein
sequence, not only in the activation loops but also in the juxta-
membrane domain. The two threonines in the activation loop
of the catalytic domain (Thr171 and Thr173) are systematically
phosphorylated (Dura´n et al., 2005). As in most of its eukaryotic
STPKs homologs, phosphorylation of these residues is essential
for PknB activation. In fact, a phosphate group from the activa-
tion loop forms an ion pair with a conserved arginine (Arg137 in
PknB) located in the catalytic loop of the catalytic domain. This
arginine is part of a conserved His-Arg-Asp motif present in
eukaryotic STPKs. In addition, the Gly-Thr-Ala motif, necessary
for the phosphotransfer between the ATP and the substrate is
also conserved in the PknB T-loop (Scheef and Bourne, 2005).
These interactions are believed to be critical to obtain the active
conformation of the catalytic site (Huse and Kuriyan, 2002). In
addition to the two phosphorylation sites, two other systematic
phosphorylated residues (Thr294 and Thr309) were identified
in the juxtamembrane domain (residues 280–330) linking theAll rights reserved
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Figure 5. Fluorescence Anisotropy Binding Profile
Fluorescence anisotropy binding profile for binding of Atto647N-labeled Rv0020c_FHA (4 nM) with PknB_331 (A), PknB_279 (B), PknB_331_ T294A
(C), PknB_331_T309A (D). See also Figure S6.
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PknB/Rv0020c Interaction StudyC-terminal end of the kinase cytoplasmic catalytic domain to the
trans-membrane domain (Dura´n et al., 2005). A similar pattern
has also been described in other M. tuberculosis STPKs such
as PknD, E, and F.
Therefore, the presence of such patterns, in combination with
the hypothesis that FHA domains could be involved in the
recruitment of substrates by STPKs, led us to investigate the
interaction between PknB and Rv0020c.
The Rv0020-FHA Domain Binds Preferentially
to the PknB Juxtamembrane Domain
We first overexpressed two constructions of the PknB kinase.
The first construction, PknB_279, is restricted to the sole cata-
lytic domain (residues 1–279) while the second one, PknB_331,
corresponds to the catalytic and juxtamembrane domains
(residue 1–331). During overexpression in Escherichia coli,
PknB autophosphorylation occurs, leading to fully phosphory-
lated samples (Dura´n et al., 2005). These two proteins were
used in fluorescence anisotropy experiments to titrate
Rv0020c_FHA protein N-terminally labeled with the Atto647N
fluorophore. The binding isotherms presented on Figure 5 were
fitted numerically according to a binding model where two
PknB proteins bind to Rv0020c_FHA. For PknB_331 (Figure 5A),
a Kd value of 110 ± 30 nM could bemeasured for the high-affinity
binding event. As the saturation plateau could not be reached
due to PknB instability at high concentration no accurate Kd
value could be obtained for the second binding event. Since
the concentration of Atto647N-labeled Rv0020c_FHA used for
the titration is limiting (4 nM), this second event probably repre-
sents the dimerization of PknB_331, which takes place in the
micromolar range (our unpublished data). The same experimentStructure 19, 1525–1was done with PknB_279 and displayed only a weak binding
event, which correspond to the binding of Rv0020c_FHA to the
catalytic domain of PknB (Figure 5B). These binding experiments
demonstrated that juxtamembrane domain is necessary for high
affinity FHA binding. The recovered affinity is similar to the one
published recently by Pennel et al. measured by isothermal
calorimetry between Rv0020c_FHA and a peptide obtained after
screening toward an oriented peptide library (Pennell et al.,
2010). In order to control whether our measured affinity was
not overestimated due to an underestimation of the PknB_331
concentration, we performed a stoichiometric titration where
Atto647N-Rv0020c_FHA was present at a concentration
(500 nM) well above the Kd for its interaction with PknB_331
(110 ± 30 nM). The binding isotherm (Figure S6) reaches a plateau
at one/one [PknB_331]/[Rv0020c_FHA] ratio, indicating that
the PknB_331 concentration was not underestimated.
The Phosphorylation Pattern of the PknB
Juxtamembrane Domain Modulates the FHA Binding
As two phosphorylation sites coexist in the juxtamembrane
domain of PknB, we investigated whether (1) both sites were
involved in the FHA binding, and (2) one was preferential. To
do so, we generated two mutant proteins by replacing one of
the phosphorylated threonine by an alanine (PknB_331_T294A
and PknB_331_T309A), thus suppressing one or the other juxta-
membrane phosphorylation site. The two proteins were used in
fluorescence anisotropy experiments to titrate Atto647N-labeled
Rv0020c_FHA (Figures 5C and 5D). Surprisingly, the two mutant
proteins displayed an even higher affinity compared with
PknB_331 (10 ± 6 nM and 13 ± 7 nM for PknB_331_T294A
and PknB_331_T309A, respectively). To date, these values534, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1529
Figure 6. Superimpositions on Selected of Rv0020c_FHA Alone and in the Presence of Peptides
Superimpositions of zooms on selected resonances in the full [1H,15N] HSQC spectra of uniformly labeled samples Rv0020c_FHA (50 mM) alone solution (black)
and in the presence of 500 mM concentrations of Pep_294 (red) or Pep_309 (blue) (A), or in the presence of Pep_294/309 (500 mM) (pink) (B). Clearly, the bound
Pep_294/309 peptide splits into two unequal populations that occupy two distinct sites at the protein surface. These two sites correspond to the binding sites
already found either for Pep_294 (75%, as measured from the relative cross-peak intensity) or for Pep_309 (25%). Spectra were recorded at 500 MHz (20C and
pH 6.8). The corresponding full spectra are presented as Figures S8 and S9. See also Figure S7.
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PknB/Rv0020c Interaction Studycorrespond to the highest affinities measured between a FHA
domain and its partner.
These results demonstrate that the concomitant phosphoryla-
tion of both threonine residues on the PknB juxtamembrane
domain is not needed for FHA binding. Moreover, a unique
phosphorylation yields a remarkable 10-fold increase in affinity.
Possibly, whether a single phosphorylation is needed to promote
the binding, a second phosphorylation disturbs this binding.
An extra characterization was attempted with the generation of
a double mutant, PknB_331_T294A_T309A, in order to assess
that phosphorylation is mandatory for the FHA binding. Unfortu-
nately and surprisingly, we were not able to obtain enough of this
mutant protein for the fluorescence anisotropy experiments.
NMR Characterizations of the PknB-Juxtamembrane/
Rv0020c-FHA Interaction
In order to understand the FHA domain interaction with the
different isoforms of PknB, we synthesized four peptides derived
from the juxtamembrane domain of PknB (residues 286–318).
The 33 amino acids peptides were either nonphosphorylated
(called Pep_NP), phosphorylated on the threonine correspond-
ing to Thr294 (PknB numbering, called Pep_294), phosphory-
lated on the threonine corresponding to Thr309 (called
Pep_309), or phosphorylated on both threonines Thr294 and
Thr309 (called Pep_294/309). Each peptide was added to
50 mM samples of 15N Rv0020c_FHA to final concentrations of
50, 250, and 500 mM respectively, and [1H,15N] HSQC spectra
were recorded.
Addition of Pep_NP did not show any modification in the
Rv0020c_FHA [1H,15N] HSQC spectrum, except for residue
Arg474 where a small concentration-dependent drift of the cor-
responding amide cross-peak was observed (Figure S7A). From
the crystal structure of Rv0020c_FHA in complex with a short
phosphopeptide published by Pennel et al. (PDB 3POA), arginine
474 participates in long live H-bonds with the phosphate and1530 Structure 19, 1525–1534, October 12, 2011 ª2011 Elsevier Ltdthe carbonyl group of pThr (Pennell et al., 2010). The peptide
concentration dependent drift suggests fast exchange condi-
tions between the FHA domain and the unphosphorylated
peptide, hence a weak binding (>100 mM). In contrast, the addi-
tion of either Pep_294 or Pep_309 changed dramatically the
[1H,15N] HSQC spectrum of Rv0020c_FHA (Figure 6A; Fig-
ure S7B), significant chemical shift variations concern amide
group in a similar region of the FHA domain, encompassing
about 20 residues (Figure 7). The fact that the variations were
found to be independent of the peptide concentration indicates
a slow exchange between the FHA protein and the peptide,
hence a high affinity (<mM). For both peptides, the most affected
cross-peaks correspond to residues belonging to the phospho-
peptide binding groove. Qualitatively, minor differences exist
upon Pep_294 or Pep_309 addition. The most notable variation
was observed for residues Thr470 and Gly471, further perturbed
when Pep_294 was added (Dv = 0.17 and 0.29 ppm against 0.13
and 0.18 ppm for Pep_309). Others discrepancies concern resi-
dues located on the loop b7/b8 centered on Asn495 (Dv = 0.23
ppm for Pep_294 against 0.13 ppm for Pep_309). These differ-
ences are likely due to local sequence differences between the
two peptides, within the segment supporting the phosphothreo-
nine residue directly involved in the interaction with the FHA
phosphopeptide binding site.
The PknB pThr294 Site Corresponds to the Preferential
Rv0020c FHA Binding Site
Addition of Pep_294/309, harboring two phosphorylations, to
Rv0020c_FHA yields essentially similar perturbations as ob-
served upon addition of Pep_294 (Figure 6B; Figure S7C). A
closer look at the HSQC spectrum revealed a second minor
population corresponding to the spectrum after addition of
Pep_309 (z25%, as estimated from cross-peak intensities).
This suggests that Rv0020C_FHA binds preferentially the pep-
tide segment bearing pThr294, although the Kd measured byAll rights reserved
Figure 7. Amide Averaged Chemical Shift Varia-
tions (Dd) as a Function of the Protein Sequence
Dd have been measured between [1H,15N] HSQC spectra
recorded at 500 MHz (20C and pH 6.8) on 50 mM
15N-uniformly labeled samples of Rv0020c_FHA before
and after addition of 500 mM concentrations of unlabeled
peptides Pep_294 (A) or Pep_308 (C), with Dd = [DdH
2+
(DdN.gN/gH)
2]0.5. The dotted line stands for the standard
deviation (0.13 ppm). The corresponding Van der Waals
diagram of the Rv0020c_FHA NMR structure are pre-
sented in (B) and (D), with a color gradient indicative of the
Dd value: from gray (Ddz0) to red (Ddmax > 0.75 ppm).
Structure
PknB/Rv0020c Interaction Studyfluorescence anisotropy between Rv0020c and PknB_T294A
or PknB_T309A were similar.
Taking as a whole, the results from the fluorescence and
NMR binding experiments display a complex mechanism of
the Rv0020c_FHA binding to PknB_331 with a modulation of
the affinity regulated by the site and the degree of phosphoryla-
tion of the juxtamembrane domain.
Conclusion
The FHA-containing proteins remain intriguing proteins. Despite
GarA and OdhI characterizations, their functions in bacteria
are still elusive. The intrinsic property of the FHA domain, a
phosphopeptide binding domain, is to link the protein to the
phosphoregulation pathway. New features of their properties
emerge, like their ability to bind nonphosphorylated peptides.
This is the case for the GarA protein, that possesses the ability
to bind its own phosphorylated N-terminal but also to nonphos-
phorylated protein. If the different binding modes have yet to
be characterized in terms of affinity, the ability of the FHA-
domain to bind to either phosphorylated or nonphosphorylated
peptides using the same binding site is still biologically efficient.
Moreover, in M. tuberculosis, their belonging to the phosphore-
gulation pathway is emphasized by the fact that the five FHA-
containing proteins are STPKs substrates.
In previous studies, we measured substrate/STPK interac-
tions. For instance, using fluorescence anisotropy, wemeasured
an 8 mMKd between Rv2175c and PknL (Cohen-Gonsaud et al.,
2009). Here, we measure a 100 to a 1000 better affinity between
Rv0020c and PknB. While the experiments were only performed
here on Rv0020c and PknB, the existence of phosphorylation
patterns on other STPK juxtamembrane domains makes
similar interactions possible for others substrate/kinase pairs.
In fact, such a binding could mean that the recruitment of the
FHA-containing substrates and as a consequence their phos-
phorylation is a priority forM. tuberculosis. Moreover, two phos-
phothreonine residues represent two independent binding sites
for Rv0020c_FHA. While the two sites coexist, we demonstrated
that the Rv0020c_FHA binds preferentially to the positionStructure 19, 1525–1534, October 12,centered on pThr294 and that phosphorylation
at position pThr309 generates a weaker affinity.
Thus, it remains difficult to speculate about
the possible biological significance of this
in vitro characterization. Nevertheless, from
the different data collected in the present study,
we could hypothesize that regulation of FHA-containing substrates could be modulated, not only by the auto-
phosphorylation of the juxtamembrane, but also by the phos-
phorylation pattern. This pattern could be established by either
STPKs or STPKs phosphatases present in M. tuberculosis.
The structures we determined, and, in particular, the structure
of Rv0020c_Nter, could not bring clear information on the puta-
tive function of Rv0020c. The structural homology between
HypA and Rv0020c_Nter appears to be an evolutionary relic,
as the conservation is limited to the core of secondary structure
and as the domain and residues linked to the metals binding
function of HypA are not present in Rv0020c. Interestingly, the
striking point concerning Rv0020c architecture corresponds to
its high degree of flexibility, as not only the protein possesses
a 300 aa unfolded central domain but also harbors on its
N-terminal part an extra 30 aa highly flexible extension. In
M. tuberculosis proteins, and STPKs substrates, in particular,
this flexible extension was shown to be important for the protein
function as demonstrated for Rv2175c and GarA. Moreover,
identification of the Rv0020c partner(s) and elucidation of the
functional role of this protein remains necessary to understand
the function of such large unfolded portion within the protein,
which surely plays an important role into the protein function.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
Strains used for cloning and expression of recombinant proteins were
Escherichia coli DH5a (Invitrogen) and E. coli BL21(DE3)Star (Novagen).
Strains were grown at 37C in LB medium supplemented with 100 mg/ml
ampicillin.
Cloning, Expression, and Purification of Recombinant Rv0020c
Proteins
The full-length Rv0020c gene was amplified by PCR using M. tuberculosis
H37Rv chromosomal DNA as a template and a set of primers containing
a NdeI and an NheI site (Table S1). The Rv0020c_Nter and Rv0020c_FHA
domains of Rv0020c were amplified by PCR using M. tuberculosis H37Rv
chromosomal DNA as a template and a set of primers containing a NdeI and
BamHI, and a NdeI and NheI site, respectively (Table 1). The amplified
products were then digested with the appropriate restriction enzymes and2011 ª2011 Elsevier Ltd All rights reserved 1531
Table 1. NMR and Refinement Statistics
Rv0020c_Nter Rv0020c_FHA
NMR distance and dihedral constraints
Distance constraints
Total NOE 1497 1296
Intraresidue 458 327
Interresidue
Sequential (ji – jj = 1) 483 416
Medium range (ji – jj < 4) 209 137
Long range (ji – jj > 5) 347 416
Intermolecular
Hydrogen bonds 92 64
Total dihedral angle
restraints
f 93 76
c 93 76
Structure statistics
Violations (mean and
standard deviation)
Maximum distance
constraint violation (A˚)
0.19 ± 0.05 0.14 ± 0.03
Maximum dihedral
angle violation ()
2.56 ± 1.01 3.25 ± 0.50
Deviations from
idealized geometry
Bond lengths (A˚) 0.0106 ± 0.0003 0.012 ± 0.001
Bond angles () 1.1328 ± 0.0370 1.257 ± 0.033
Impropers () 1.3694 ± 0.0996 1.423 ± 0.103
Ramachandran plot (%)
Most favored region 87.0 85.8
Additionally allowed region 12.9 12.7
Generously allowed region 0.1 1.3
Disallowed region 0.0 0.2
Average pairwise rmsd (A˚) Residues 37–122 Residues 436–527
Backbone 1.09 ± 0.23 1.02 ± 0.22
Heavy 1.82 ± 0.24 1.66 ± 0.22
Pairwise rmsd was calculated among 30 refined structures.
Structure
PknB/Rv0020c Interaction Studyligated into the pET_Tev plasmid harboring a variant of the His-tag fusion
vector pET-15b, which was modified to contain a tobacco etch virus (TEV)
protease site to replace the thrombin site coding sequence. All plasmids
were verified using DNA sequencing. Site-directed mutagenesis on Rv0020c
phosphorylation site was carried out according to the Stratagene Quick-
Change XL site-directed mutagenesis manual. Primers used for mutagenesis
are detailed in Table 1. Mutation of the phosphorylated threonine residue of
Rv0020c was created by substitution of Thr116 with alanine. The presence
of the desired mutations was confirmed by sequencing.
All constructs were expressed as Tev-protease cleavable His-fusions in
E. coli BL21 (DE3) star competent cells (Invitrogen). Recombinant strains
harboring the different constructs were used to inoculate a 2 liter flask contain-
ing 750 ml of L-broth supplemented with 100 mg/ml ampicillin. The culture was
grown in an orbital incubator set at 37C and 220 rpm, until the A600 of the
culture reached 0.6 and then IPTG was added at a final concentration of
0.2 mM in order to induce the expression of Rv0020c proteins. Growth of
the cultures was continued for a further 3 hr at a lower temperature of 30C,
after which the cells were harvested by centrifugation (using a Beckman
Coulter Avanti J-20 XP centrifuge equipped with a 10,500 rotor and set at1532 Structure 19, 1525–1534, October 12, 2011 ª2011 Elsevier Ltd7C and 8000 rpm). The cell pellet arising from the 750 ml of culture was
resuspended, on ice, in 30 ml of buffer A (50 mM Tris-HCl [pH 8.5], 150 mM
NaCl) and 50 ml of 10mg/ml lysozymewas added to aid in digestion of the cells.
Cell pellets were stored at 80C until required. Cells were then lysed by
sonication (2 s bursts for 5 min, at 60% amplitude, with a large parallel probe;
Vibra cell 72405), after which cell debris and insoluble materials were removed
by centrifugation (using a Beckman Coulter Avanti J-20 XP centrifuge equip-
ped with a 25.50 rotor, set at 18,000 rpm, at 7C). The supernatant arising
from this step was filtered through a 0.22 mm PVDF filter (Millipore) and then
loaded through a AKTA basic system into a Hitrap 1 ml IMAC HP column
(Amersham Biosciences), equilibrated in buffer A and 4% of buffer B (50 ml
of buffer A supplemented with 500 mM of imidazole). Ni2+-agarose affinity
chromatography was then carried out at room temperature, to purify the
His-tagged recombinant protein. The column was washed with successive
applications of buffer A and 4% of buffer B (approximately 30 ml in total) to re-
move all the impurities and then buffer B was increased over 20 ml to 100%,
which was collected in fractions of 0.5 ml. Fractions containing the Rv0020c
proteins were identified by SDS-PAGE, then pooled and concentrated, using
a 5 K cutoff concentrator, to a final volume of 5 ml (using a Sigma laborzentri-
fugh 3K15 bioblock scientific centrifuge set at 7C, 4000 3 g). The concen-
trated protein was applied to a Hiprep 26/10 (Amersham Biosciences) desalt-
ing column equilibrated in buffer A, to remove the imidazole in order to increase
protein stability. The first two 5ml fractions eluted, corresponded to the protein
and so were pooled (total volume 10 ml) and placed in a labeled 15 ml falcon
tube. The solution was treated for 2 hr at room temperature with TEV protease
(approximately 1 OD of TEV for 100 OD of protein), to digest and thereby
remove the N-terminal His-tag from the protein. Finally, the 10 ml of protein
was concentrated (as before) to a final volume of 2 ml and applied to a Super-
dex 75 26/60 (Amersham Biosciences) size exclusion column, equilibrated
in buffer 20 mM Na-Phosphate (pH 6.2), 150 mM NaCl. This led to the removal
of any remaining impurities and the tag. Again, fractions containing the
Rv0020c protein were identified by SDS-PAGE and then pooled and stored
at 20C until required. This protocol was carried out for all the nonlabeled
constructs of Rv0020c as well as for 15N and 15N -13C-labeled Rv0020c
constructs, except that the cultures were grown in a minimum media contain-
ing 15NH4Cl and
15NH4Cl/
13C6 glucose as the sole nitrogen and carbon
sources.
Cloning, Expression, andPurification of Recombinant PknBProteins
The kinase domain (1–279) or the kinase domain with the juxtamembrane
domain (1–331) of PknB were amplified by PCR using M. tuberculosis
H37Rv chromosomal DNA as a template and a set of primers containing
a NdeI and a BamHI site (Table S1). The amplified products were then digested
with the appropriate restriction enzymes and ligated into the pET15b-TEV
vector. All plasmids were verified using DNA sequencing. E. coli BL21(DE3)
Star cells were transformed with the pET15b-TEV vector derivatives express-
ing the various PknB domain proteins. Recombinant E. coli strains harboring
the pET15b-TEV derivatives were used to inoculate 200 ml of LB medium sup-
plemented with ampicillin and incubated at 37C with shaking until A600
reached 0.5. Isopropyl 1-thio-b-D-galactopyranoside was then added at a final
concentration of 0.5 mM, and growth was continued for an additional 5 hr
period at 25C. The cells were harvested by centrifugation at 6000 3 g for
10 min, washed in 10 ml of buffer A (50 mM Tris-HCl [pH 7.5], 150 mM NaCl,
10% glycerol, 1 mM EDTA, 1 mM aprotinin) and centrifuged again under the
same conditions. The cell pellet was resuspended in buffer A. Cells were dis-
rupted in a French pressure cell at 16,000 psi. The resulting suspension was
centrifuged at 4C for 30 min at 20,000 3 g.
The supernatant was loaded through a AKTA basic system into a Hitrap 1 ml
IMAC HP column (Amersham Biosciences), equilibrated in buffer A and 4%
of buffer B (50 ml of buffer A supplemented with 500 mM of imidazole).
Ni2+-agarose affinity chromatography was then carried out at room tempera-
ture, to purify the His-tagged recombinant protein. The column was washed
with successive applications of buffer A and 4% of buffer B (approximately
30 ml in total) to remove all the impurities and then buffer B was increased
over 20 ml to 100%, which was collected in fractions of 0.5 ml. Fractions con-
taining the OdhI protein were identified by SDS-PAGE, then pooled and
concentrated, using a 5 K cutoff concentrator, to a final volume of 5 ml. The
concentrated protein was applied to a Superdex S75 16/10 (AmershamAll rights reserved
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PknB/Rv0020c Interaction StudyBiosciences) column equilibrated in buffer C (40mMTris-HCl [pH 7.9], 200mM
NaCl, 0.2 mM DTT, 0.2 mM EDTA, 10% glycerol), and pure fractions were
pooled.
Fluorescence Anisotropy
Rv0020c_Nter was covalently labeled with Atto647N succinimidyl ester dye
(Invitrogen). A 10-fold molar excess of the dye was added to a solution of
protein in 0.1 M sodium phosphate (pH 7.2) buffer and the reaction was
allowed to proceed at room temperature for 3 hr with continuous agitation.
The reaction was stopped by adding 10% Tris-HCl 1 M, and the excess of
free dye was removed on a PD-10 column. Steady-state fluorescence anisot-
ropy binding titrations were carried out on a Tecan Saphire II microplate
reader, using a 635 nm LED for excitation, and a monochromator set at
680 nm (bandwidth 20 nm) for emission.
Binding data were analyzed using the package BIOEQS (Royer et al., 1990),
a program that allows the fitting of the binding isotherm in terms of dissociation
constants implicit in the model of choice. The simultaneous set of nonlinear
free energy equations associated with the model is solved numerically in terms
of the concentrations of the individual species postulated to exist.
The model, which was employed to fit the binding profiles, corresponds to
the case where two PknB proteins bind to Rv0020c_FHA. Uncertainties on
the recovered parameters were obtained by repeating a complete minimiza-
tion over a range of tested parameter values, allowing all other parameters
to float. The reported errors represent the uncertainties at the 67% confidence
limit (i.e., 1 standard deviation) taking into account the correlation between all
the parameters in the fits.
In Vitro Kinase Assays
In vitro phosphorylation by PknB was carried out for 30 min at 37C in a reac-
tion mixture (20 ml) containing buffer P (25 mM Tris-HCl [pH 7.0]; 1 mM DTT;
5 mM MgCl2; 1 mM EDTA) with 200 mCi/ml [g-
33P]ATP. Phosphorylation of
Rv0020c by PknB derivatives was performed with 5 mg of Rv0020c in 20 ml
of buffer P with 200 mCi/ml [g-33P]ATP and 500 ng of PknB derivatives for
30 min at 37C. The reaction was stopped by addition of an equal volume of
2 3 sample buffer and the mixture was heated at 100C for 5 min. After elec-
trophoresis, gels were soaked in 16% TCA for 10 min at 90C, and dried.
Radioactive proteins were visualized by autoradiography using direct expo-
sure to films.
In vitro phosphorylation for NMR and mass spectrometry analysis was per-
formed as described above except that [g-32P]ATP was replaced by 5 mM
nonradioactive ATP and incubated overnight.
Mass Spectrometry Analysis
Purified Rv0020c was subjected to in vitro phosphorylation as described
above. Subsequent mass spectrometry analyses were performed as previ-
ously described (Fiuza et al., 2008).
Solution Structure of Rv0020c_Nter and Rv0020c_Cter
All NMR experiments were generally carried out at 20C on Bruker Avance III
700 (1H-15N double resonance experiments) or Avance III 500 (1H-13C-15N
triple-resonance experiments) spectrometer equipped with 5 mm z-gradient
TCI cryoprobe, using the standard pulse sequences (Sattler et al., 1999).
NMR samples consist on approximately 0.5 mM 15N- or 15N,13C-labeled
protein dissolved in 10 mM phosphate buffer, 100 mM NaCl (pH 6.8) with
5% D2O for the lock.
1H chemical shifts were directly referenced to the methyl
resonance of DSS, while 13C and 15N chemical shifts were referenced indi-
rectly to the absolute 15N/1H or 13C/1H frequency ratios. All NMR spectra
were processed and analyzed with GIFA (Pons et al., 1996).
NOE cross-peaks identified on 3D [1H,15N] NOESY-HSQC were assigned
through automated NMR structure calculations with CYANA 2.1 (Gu¨ntert,
2004). Backbone 4 and f torsion angle constraints were obtained from
a database search procedure on the basis of backbone (15N, HN, 13C’, 13Ca,
Ha, 13Cb) chemical shifts using the program TALOS (Cornilescu et al., 1999).
Hydrogen bond restraints were derived using standard criteria on the basis
of the amide 1H / 2H exchange experiments and NOE data. When identified,
the hydrogen bond was enforced using the following restraints: ranges of
1.8–2.3 A˚ for d(N-H,O), and 2.7–3.3 A˚ for d(N,O). The final list of restraints,
from which values redundant with the covalent geometry has been eliminated.Structure 19, 1525–1The 30 best structures (based on the final target penalty function values) were
minimized with CNS 1.2 according the RECOORD procedure (Nederveen
et al., 2005) and analyzed with PROCHECK (Laskowski et al., 1993). The rmsds
were calculated with MOLMOL (Koradi et al., 1996). All statistics are given in
Table 1.
ACCESSION NUMBERS
The structure coordinates for the N- and C-terminal domains have been
deposited in the Protein Data Bank (www.rcsb.org/pdb/) as entries 2LC0
and 2LC1, respectively. The chemical shifts have been deposited in the
BioMagResBank under the accession numbers BMRB-17585 and BMRB-
17586.
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